title: Mifepristone for the treatment of uterine leiomyomas: methodological issues and clinical implications.
authors.affiliation: Epidemiology and Biostatistics Unit, Department of Obstetrics and Gynaecology, Scientific Direction, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Erenbourg
authors.forename: Monica
authors.initials: M
authors.lastname: Piccoli
authors.forename: Luca
authors.initials: L
authors.lastname: Ronfani
authors.forename: Giorgio
authors.initials: G
authors.lastname: Tamburlini
mesh_terms: D005260:Female; D006727:Hormone Antagonists / Q000008:administration & dosage*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000473:pathology; D015735:Mifepristone / Q000008:administration & dosage*; D009929:Organ Size / Q000187:drug effects; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014599:Uterus / Q000033:anatomy & histology
chemical_list: D006727:Hormone Antagonists; D015735:Mifepristone